re: MEIP vs. CRIS
McBio,
You neglected to mention, as you usually do, the respective market caps of the two companies. Furthermore, CRIS has over 4X the outstanding shares of MEIP. And MEIP has a much stronger management team, IMO, at least on paper.
You tend to assume that a dual inhibitor is necessarily better than a single inhibitor, and I don't think that is necessarily always the case.
Bladerunner
P.S. I own both, but a much larger position in MEIP